A Novel BCR-ABL Fusion Gene (e6a2) in a Patient With Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia

A novel variant of the chimeric BCR-ABL mRNA transcript was detected in a patient with Philadelphia chromosome-negative (Ph-) chronic myelogenous leukemia (CML) by multiplex reverse-transcription polymerase chain reaction (RT-PCR). Sequence analysis of the fusion region of the amplified cDNA fragmen...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 88; no. 6; pp. 2236 - 2240
Main Authors Hochhaus, A., Reiter, A., Skladny, H., Melo, J.V., Sick, C., Berger, U., Guo, J.Q., Arlinghaus, R.B., Hehlmann, R., Goldman, J.M., Cross, N.C.P.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 15.09.1996
The Americain Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel variant of the chimeric BCR-ABL mRNA transcript was detected in a patient with Philadelphia chromosome-negative (Ph-) chronic myelogenous leukemia (CML) by multiplex reverse-transcription polymerase chain reaction (RT-PCR). Sequence analysis of the fusion region of the amplified cDNA fragment showed an in-frame joining of exon e6 of the BCR gene and exon a2 of the ABL gene, giving rise to an e6a2 BCR-ABL transcript. This finding was confirmed by Southern blot analysis using a specific probe corresponding to intron 6 of the BCR gene, whereas conventional Southern blot for rearrangement of the major breakpoint cluster region (M-bcr) was negative. Western blot studies detected a BCR-ABL protein slightly larger than p185 BCR-ABL. Meta-phase fluorescence in situ hybridization showed an insertion of ABL material into the BCR region without reciprocal BCR translocation. The findings in this case show that atypical BCR-ABL transcripts are detectable even in Ph- CML patients without M-bcr-rearrangements. Multiplex PCR using primers that allow for amplification of all known BCR-ABL transcripts is an appropriate method to exclude these rare variants.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V88.6.2236.bloodjournal8862236